C17 Glucosyl(beta) Ceramide (d18:1/17:0)
| Catalog Number | BL-M001106 |
| CAS Number | 1252807-00-3 |
| Description | C17 Glucosyl(beta) Ceramide (d18:1/17:0) A key compound investigated in scientific research for its significance in intricate cellular communication networks, specifically exploring its implications in the pathogenesis of various conditions like cancer and neurodegenerative ailments. |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]heptadecanamide |
| Synonyms | D-glucosyl-beta-1,1'-N-heptadecanoyl-D-erythro-sphingosine; C17 beta-D-Glucosyl Ceramide |
| Molecular Weight | 714.07 |
| Molecular Formula | C41H79NO8 |
| Boiling Point | 850.3±65.0 °C at 760 mmHg |
| Purity | >99% |
| Density | 1.1±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 68.96%, H 11.15%, N 1.96%, O 17.92% |
| Canonical SMILES | CCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C41H79NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37(45)42-34(33-49-41-40(48)39(47)38(46)36(32-43)50-41)35(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h28,30,34-36,38-41,43-44,46-48H,3-27,29,31-33H2,1-2H3,(H,42,45)/b30-28+/t34-,35+,36+,38+,39-,40+,41+/m0/s1 |
| InChI Key | VQADGGHNXABKOV-VIBFQTAGSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry